Cell cycle regulation of a Xenopus Wee1-like kinase by Mueller, Paul R. et al.
Molecular Biology of the Cell
Vol. 6, 119-134, January 1995
Cell Cycle Regulation of a Xenopus Weel-like Kinase
Paul R. Mueller, Thomas R. Coleman, and William G. Dunphy*
Division of Biology 216-76, Howard Hughes Medical Institute, California Institute of Technology,
Pasadena, California 91125
Submitted October 21, 1994; Accepted December 5, 1994
Monitoring Editor: Tim Hunt
Using a polymerase chain reaction-based strategy, we have isolated a gene encoding a
Weel-like kinase from Xenopus eggs. The recombinant Xenopus Weel protein efficiently
phosphorylates Cdc2 exclusively on Tyr-15 in a cyclin-dependent manner. The addition
of exogenous Weel protein to Xenopus cell cycle extracts results in a dose-dependent
delay of mitotic initiation that is accompanied by enhanced tyrosine phosphorylation of
Cdc2. The activity of the Weel protein is highly regulated during the cell cycle: the
interphase, underphosphorylated form of Weel (68 kDa) phosphorylates Cdc2 very
efficiently, whereas the mitotic, hyperphosphorylated version (75 kDa) is weakly active
as a Cdc2-specific tyrosine kinase. The down-modulation of Weel at mitosis is directly
attributable to phosphorylation, since dephosphorylation with protein phosphatase 2A
restores its kinase activity. During interphase, the activity of this Weel homolog does not
vary in response to the presence of unreplicated DNA. The mitosis-specific phosphory-
lation of Weel is due to at least two distinct kinases: the Cdc2 protein and another
activity (kinase X) that may correspond to an MPM-2 epitope kinase. These studies
indicate that the down-regulation of Weel-like kinase activity at mitosis is a multistep
process that occurs after other biochemical reactions have signaled the successful com-
pletion of S phase.
INTRODUCTION
All eukaryotic cells must replicate their DNA during S
phase and distribute the resulting identical copies of
their genetic information to daughter cells at mitosis.
In most cells, the processes of chromosomal replica-
tion and segregation must be both coordinated with
overall cellular growth and integrated with regulatory
pathways that ensure the integrity of the genome. Cell
cycle events such as S phase and mitosis are triggered
by a large family of cyclin-dependent kinases (Cdks)
that consist of a cyclin regulatory subunit and a Cdk
catalytic partner. In turn, the cyclin-dependent kinases
are controlled by a variety of regulatory factors, many
of which govern the state of Cdk phosphorylation.
These Cdk regulators must directly or indirectly re-
spond to factors that control various checkpoints such
as those involved in the monitoring of cell size, ge-
nome integrity, and mitotic spindle assembly [for re-
views, see Hartwell and Weinert (1989), Nurse (1990),
Solomon (1993), and Dunphy (1994)].
* Corresponding author.
At the G2/M transition, a Cdk-cyclin complex known
as maturation promoting factor (MPF) induces mitosis
by phosphorylating a variety of structural and regula-
tory proteins that control mitotic processes such as chro-
mosome condensation, spindle assembly, and nuclear
envelope breakdown. MPF consists of the Cdc2 protein
kinase (the archetypal member of the Cdk family) and a
number of B-type cyclins (Dunphy et al., 1988; Draetta et
al., 1989; Gautier et al., 1988; Murray and Kirschner,
1989). The activation of MPF is controlled both transla-
tionally by the accumulation of the cyclin protein and
posttranslationally by three known phosphorylations of
the Cdc2 subunit. An enzyme known as CAK (Cdk-
activating kinase) must phosphorylate Cdc2 on Thr-161
for acquisition of MPF activity but concomitant, domi-
nantly inhibitory phosphorylations on Tyr-15 and Thr-14
serve to suppress the kinase activity of MPF during
interphase [reviewed in Draetta (1993), Pines (1993), So-
lomon (1993)]. The Weel protein kinase phosphorylates
Cdc2 on Tyr-15 but apparently not Thr-14 (McGowan
and Russell, 1993; Parker and Piwnica-Worms, 1992;
Kombluth et al., 1994). At the onset of mitosis, a highly
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regulated phosphatase called the Cdc25 protein activates
MPF by dephosphorylating Tyr-15 and most probably
Thr-14 (Dunphy and Kumagai, 1991; Gautier et al., 1991).
A variety of studies have suggested that both the
Cdc25 and Weel proteins are highly regulated during
the cell cycle. In the case of the Cdc25 protein, much is
known about the molecular mechanisms that control
its Cdc2-specific tyrosine phosphatase activity. Specif-
ically, a stimulatory kinase activity phosphorylates the
N-terminal regulatory domain of the Cdc25 protein at
the G2/M transition, thereby allowing the C-terminal
catalytic domain to dephosphorylate Cdc2 (Kumagai
and Dunphy, 1992; Izumi et al., 1992; Clarke et al.,
1993; Hoffman et al., 1993). Considerably less is known
about Weel regulation. Indirect measurements have
indicated that Weel activity is high during interphase
and low during mitosis, and experiments with heter-
ologous in vitro systems have provided evidence that
the inactivation of Weel at mitosis is due to phosphor-
ylation (Solomon et al., 1990; Smythe and Newport,
1992; Devault et al., 1992; Tang et al., 1993). However,
the extent to which the modulation of Weel activity
contributes to the mitotic-decision mechanism re-
mains unresolved. In addition, the relationship be-
tween Weel regulation and the various cell cycle
checkpoints, such as the one that monitors unrepli-
cated DNA, is an important issue. These problems can
be addressed best by examining the regulation of
Weel kinase activity throughout the cell cycle in a
homologous system. The Xenopus system is well
suited for this purpose in that extracts from Xenopus
eggs perform the cell cycle in vitro [reviewed in Mur-
ray (1991)]. Moreover, it has been possible to prepare
Xenopus egg extracts containing unreplicated DNA
that remained arrested in interphase due to the action
of one or more inhibitory, replication-checkpoint fac-
tors (Dasso and Newport, 1990; Kornbluth et al., 1992;
Kumagai and Dunphy, 1992).
In this report, we describe the cloning and func-
tional characterization of a Weel-like kinase present in
Xenopus eggs. With peptide-specific antibodies, we
have isolated Xenopus Weel from egg extracts and
measured its kinase activity and phosphorylation state
at various points in the cell cycle. The kinase activity
of Xenopus Weel is highly regulated during the cell
cycle by phosphorylation, but the presence of unrep-
licated DNA during interphase does not appear to
affect its activity or phosphorylation state to any mea-
surable extent. We present evidence that the Weel
protein is phosphorylated by multiple kinases at the
G2/M transition when it undergoes a large reduction
in its ability to phosphorylate Cdc2. Since one of these
Weel-specific kinases corresponds to Cdc2, it appears
that the down-modulation of Weel at mitosis involves
in part a self-perpetuating loop where some active
Cdc2 helps to trigger the full activation of MPF. In
addition, the other Weel-specific kinase (kinase X)
may play a crucial role in mitotic initiation.
MATERIALS AND METHODS
cDNA and Library Production
Total RNA was prepared from de-folliculated mature Xenopus oo-
cytes by a variation of the method of Chomczynski and Sacchi
(1986). After the initial extraction with acidic phenol, the sample
was clarified by centrifugation (16,000 x g for 10 min). The soluble
fraction was extracted two times with 49% phenol/49% chloro-
form/2% isoamyl alcohol and then further purified by centrifuga-
tion through a 5.7 M CsCl cushion (Chirgwin et al., 1979) with
subsequent extractions and precipitations as described by Mueller et
al. (1988). Poly(A)+ RNA was prepared as described (Sambrook et
al., 1989) except that sodium dodecyl sulfate (SDS) was omitted
from the elution buffer.
cDNA was synthesized by a variation of the hemimethylated
protection method described by Palazzolo et al. (1990). First strand
synthesis was performed at 42°C with poly(A)+ Xenopus oocyte
RNA and Superscript reverse transcriptase (Life Technologies, Inc.,
Gaithersburg, MD) in the presence of RNasin (Promega, Madison,
WI), 5-methyl dCTP (Novagen, methylation dNTP mix), and a
XhoI/oligo dT primer (Stratagene, La Jolla, CA). Second strand
synthesis was performed at 15'C by using E. coli DNA polymerase
I (New England BioLabs, Beverly, MA), ribonuclease H (Promega),
and Escherichia coli DNA ligase (Life Technologies, Inc.) in the
presence of normal dNTPs (Pharmacia Biotech Inc., Piscataway, NJ).
Doubled-stranded cDNA was blunt-ended with T4 DNA poly-
merase (New England BioLabs) at 15°C before ApaI linkers (New
England BioLabs) were added by T4 DNA ligase (New England
BioLabs). Finally, the cDNA was digested with ApaI and XhoI,
leaving the 5' and 3' ends of each insert flanked by ApaI and XhoI
sticky ends, respectively. Since neither restriction enzyme cleaves
hemimethylated DNA efficiently, internal ApaI and XhoI sites of the
cDNA remain undigested. The cDNA was then used either for
degenerate polymerase chain reaction (PCR) (see below) or direc-
tionally ligated into the cloning vector pAX-SV40 (P. R. Mueller and
W. G. Dunphy, unpublished results) that had been digested with
ApaI and XhoI. The cDNA/vector ligation reaction was transformed
into the methylcytosine tolerant DH1OB strain of E. coli (Electro-
MAX DH10B, Life Technologies, Inc.) by electroporation, and ulti-
mately 4.1 X 106 transformants where recovered by carbenicillin
selection on 15-cm LB plates. Approximately 6.3 x 104 colonies/
plate where grown to an average colony size of 0.5 mm before they
were aseptically pooled from all plates by scraping into growth
media. The library-transformed bacteria were then frozen in ali-
quots of 15% glycerol and stored at -80°C.
Isolation of a cDNA Encoding a Xenopus Weel-like
Protein Kinase
An internal Xenopus Weel fragment was cloned by PCR amplifica-
tion using degenerate primers specific to regions of high amino acid
sequence similarity shared between the Schizosaccharomyces pombe
Weel, S. pombe Mikl, and human Weel proteins (see Figure 1B). The
5' primer was CGCGGATCC(C/T)(T/A)IGT(I/C)CA(C/T)(A/C/
T)TIGA(C/T)(I/C)T(I/C)AA(A/G)CC and the 3' primer was TC
CCCCGGGTGCCAI(T/G/C)II(T/A)(C/G)ICC(G/A)TT(I/C)(C/T)
(G/T/C)(I/C)GG. The 5' end of each primer contains nine extra
nucleotides (underlined) that provide restriction sites for BamHI or
SmaI. PCR reactions (50 ,ul) contained 20 ng Xenopus oocyte cDNA
as template, 150 pmol of each primer, dNTPs, and buffer conditions
recommended by the manufacturer. The reactions were heated to
85'C, and 1.25 units Taq DNA polymerase (AmpliTaq, Perkin-
Elmer, Norwalk, CT) were added. Next, the reactions were heated
to 94'C for 2.5 min followed by 95°C for 0.5 min. The reactions were
then cycled 35 times at: 94°C for 1 min, 52°C for 2 min, and 72'C for
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2 min with 5 s added to the extension phase of each successive cycle.
In addition, an extra 5 min were added to the last 72°C extension
step. An aliquot (20 ,ul) of the reaction was run on a 2% low melting
point agarose gel, and an -320-bp DNA band was isolated and
subcloned into the TA II cloning vector (Invitrogen, San Diego, CA).
DNA sequencing of 15 clones revealed one class of insert that had
strong sequence similarity to the S. pombe Weel, S. pombe Mikl, and
human Weel proteins. This fragment was radiolabeled and used to
screen the Xenopus oocyte cDNA library by colony hybridization
(Sambrook et al., 1989; Ausubel et al., 1994). A full-length clone
(pXe-Weel) was selected for further study and sequenced on both
strands by primer walking using Sequenase (U.S. Biochemical,
Cleveland, OH) with the dideoxy chain termination method.
Plasmid Construction for Xenopus Weel Protein
Production
To synthesize full-length Xenopus Weel recombinant protein, the
initiation codon was converted to an NdeI restriction site by PCR.
The 5' PCR primer, CGGCAtATGAGGACGGCCATGTCATG, is
complementary to the beginning of the open reading frame of
Xenopus Weel (see Figure 1A) except that a single thymine (t, small
case) was added. This extra base adds an NdeI site (underlined) to
the initiation site. The 3' PCR primer, AGCTTGAGCTTCTTCCAT-
GTGCTG, is complementary to the region of Xenopus Weel imme-
diately downstream of an unique KpnI site (nucleotide 253, Figure
1A). PCR was performed using 200 ng of pXe-Weel in a 50-,ul
reaction under the conditions recommended by the manufacturer in
the presence of 1 unit of AmpliTaq DNA polymerase (Perkin-
Elmer). The reactions were heated to 94°C for 2.5 min followed by
95°C for 0.5 min and then cycled 30 times at: 94°C for 1 min, 55°C
for 2 min, and 72°C for 2 min. In addition, an extra 7 min were
added to the last 72°C extension step. The PCR reaction was used
directly for subcloning into TA II (Invitrogen) as recommended by
the manufacturer. The sequence of the modified Xenopus Weel
fragment in the plasmid was confirmed by sequencing. This was
then digested with NdeI and KpnI to generate a 262-bp fragment
containing the modified 5' portion of Xenopus Weel (Xe-Weel),
which together with the -1750 bp KpnI/XhoI 3' portion of Xe-Weel,
was ligated into either pET3a (Studier et al. 1990), pET3a-HIS (A.
Kumagai and W. G. Dunphy, unpublished results), or pVL1393N-
HIS (Tang et al., 1993). The resulting vectors (pET-XeWeel, pET-
HIS-XeWeel, and pVL-HIS-XeWeel) were used for preparation of
Xenopus Weel protein (untagged or histidine-tagged, as indicated)
in reticulocyte lysates, bacteria, or Sf9 insect cells.
Antibody Production
Rabbits were immunized with either a peptide corresponding to the
C-terminal end of Xenopus Weel (VGAKNTRSLSFTCGGY) conju-
gated to keyhole limpet hemocyanin or purified, full-length Xenopus
Weel protein expressed in bacteria (see below). Anti-peptide anti-
bodies were purified by affinity chromatography on Affi-Gel-10
columns (Bio-Rad, Richmond, CA) containing covalently bound
peptides. Antibodies against Xenopus Cdc2 (Milarski et al., 1991) and
fission yeast Weel (Tang et al., 1993) were prepared as described.
Antibodies against human cyclin BI (GNS-1) and phosphotyrosine
(4G10) were obtained from Pharmingen, San Diego, CA, and Up-
state Biotechnology, Lake Placid, NY, respectively. The MPM-2
antibodies were a generous gift of J. Kuang.
Production and Purification of Proteins from
Baculovirus-Infected Insect Cells and Bacteria
Sf9 insect cell lysates containing histidine-tagged Xenopus Weel,
histidine-tagged human cyclin BI (A. Kumagai and W. G. Dunphy,
unpublished data), wild type Xenopus Cdc2 (Coleman et al., 1993),
mutant Xenopus Cdc2 (T161A, T14A, or Y15F) (A. Kumagai and W.
G. Dunphy, unpublished data), and histidine-tagged fission yeast
Weel (Tang et al., 1993) were prepared by established procedures
(Desai et al., 1992). Xenopus Cdc2-containing lysates were aliquoted,
frozen in liquid nitrogen, and stored at -80°C. Histidine-tagged
proteins were immediately bound to nickel-iminidoacetic acid
(IDA) Sepharose (Sigma Chemical, St. Louis, MO) and either frozen
directly in liquid nitrogen for later use or purified as described (A.
Kumagai and W. G. Dunphy, unpublished data) except that in the
case of histidine-tagged Weel protein the elution buffer contained 5
mM 2-mercaptoethanol. Proteins which were added to Xenopus egg
extracts were dialyzed against 10 mM N-2-hydroxyethylpiperazine-
N'-2-ethanesulfonic acid (HEPES)-NaOH, pH 7.4, 150 mM NaCl,
and 0.1 mM dithiothreitol.
A plasmid encoding histidine-tagged full-length Xenopus Weel
protein (pET-HIS-XeWeel) was transformed into BL21(DE3)pLysS.
These bacteria were grown to mid-log phase, induced, harvested,
and lysed essentially as described (Kumagai and Dunphy, 1991)
except induction was at 37°C and sonication was performed in 20
mM HEPES-NaOH, pH 7.4, 150 mM NaCl, 5 mM 2-mercaptoetha-
nol, 5 mM ethylene glycol-bis(,B-aminoethyl ether)-N,N,N',N'tet-
raacetic acid (EGTA), and 0.1% Nonidet P-40. The inclusion body
fraction was dissolved in 20 mM Tris-HCl, pH 8.0, 0.5 M NaCl, and
6 M urea. Following clarification (20 min at 30,000 x g), the urea-
solubilized protein was purified by nickel-IDA Sepharose chroma-
tography as described above. A highly enriched 68-kDa band cor-
responding to the Xenopus Weel protein was purified to
homogeneity by electroeluting in an Elutrap (Schleicher & Schuell,
Keene, NH). The pure protein was used as a standard to estimate
the concentration of endogenous Weel protein in Xenopus extracts
and for antibody production.
Assay for Xenopus Weel-mediated Tyrosine
Phosphorylation of Cdc2
Purified complexes between histidine-tagged human cyclin BI and
either wild type or mutant Xenopus Cdc2 were prepared as de-
scribed (A. Kumagai and W. G. Dunphy, unpublished data). In
some cases, Xenopus Cdc2 was isolated from insect cell lysates on
agarose beads containing the fission yeast Sucl protein (p13) at a
concentration of 5 mg/ml (Dunphy et al., 1988). The Xenopus Cdc2
protein was eluted from the beads by treatment with 0.15 mg/ml
Xenopus Sucl protein (our unpublished data) dissolved in lysis
buffer. This purified Cdc2 protein was added to the eluted, histi-
dine-tagged human cyclin BI to yield to the Cdc2/cyclin B sub-
strate. Control experiments indicated that the Xenopus Sucl protein
did not affect the Weel kinase assay.
Two in vitro kinase assays were developed to measure the kinase
activity of the Xenopus Weel protein. In the first, Xenopus Weel
(recombinant or immunoisolated from Xenopus extracts) was com-
bined with the purified Cdc2/cyclin B substrate (either wild-type
Cdc2 or the Cdc2T161A mutant) and an ATP regenerating system
essentially as described (Coleman et al., 1993) except that MnCl2 was
omitted from the kinase buffer and the reaction was performed at
21°C. Following this incubation, samples were processed for immu-
noblotting. In the second assay, Xenopus Weel was combined with
the purified kinase-negative substrate (Cdc2T161A/cyclin B) in ki-
nase buffer in the presence of [32P]ATP (125 ,zCi/ml). In some cases,
a 10-fold excess of non-radioactive ATP was included. Following a
15-20-min incubation at 21°C, samples were processed for autora-
diography.
Xenopus Egg Extracts
Xenopus cytostatic factor (CSF)-arrested egg extracts (arrested in M
phase) were prepared from unactivated eggs as described by Mur-
ray (1991). To drive these extracts into interphase and observe their
cell cycle progression, CaCl2 (0.4 mM) and demembranated Xenopus
sperm nuclei (200/,ul) were added. In some cases, extracts were
arrested in interphase with either cycloheximide (100 ,tg/ml) or
aphidicolin (50
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,ug/ml in the presence of 1000-2000 sperm nuclei per ,ul of egg
extract).
Cytosolic and membrane fractions from either CSF-arrested or
interphase-arrested (40 min post-activation) Xenopus egg extracts
were prepared by diluting the extracts with 2 volumes of EB buffer
(80 mM sodium ,3-glycerol phosphate, pH 7.3, 15 mM MgCl2, 20
mM EGTA) containing 3 ,uM okadaic acid and protease inhibitors
(10 ,ug/ml each of pepstatin, chymostatin, and leupeptin), and
centrifuged at 260,000 x g for 1 h at 4°C. Membrane fractions were
resuspended in EB (volume equal to cytosol).
Preparation of Cdc2-depleted CSF Cytosol
Cytosolic fractions of CSF-arrested Xenopus extracts were incubated
with 0.1 volume of either control-agarose beads or p13-agarose
beads (5 mg/ml bound p13) for 30 min at 4°C. Beads were removed
by centrifugation (10 s at 1400 x g). To ensure quantitative Cdc2
removal, extracts were reincubated with fresh p13-agarose beads for
a total of four times.
Isolation of Endogenous Cdc2 and Weel from
Xenopus Extracts on p13-Agarose
Aliquots of a calcium-activated egg extracts were taken at various
intervals and frozen in liquid nitrogen. Subsequently, these aliquots
were thawed, diluted with 2 volumes of EB buffer containing 25mM
NaF and 1 mM Na3VO4, clarified by centrifugation (5 min, 16,000 x
g) and incubated under constant agitation with 0.25 volume of
p13-agarose beads (5 mg/ml bound p13) for 30 min at 4°C. Follow-
ing this incubation, the beads were processed as described in (So-
lomon et al., 1990) except that dithiothreitol was omitted from the
washes.
Immunoisolation of Endogenous Xenopus Weel
Protein
Nonionic detergent (Nonidet P-40, 1% final concentration) was
added to aliquots of either CSF-arrested, interphase or S phase egg
extracts. Next, these extracts were incubated with affinity purified
anti-Xenopus Weel peptide antibodies (44 Ag/ml) for 1 h at 4°C.
Subsequently, protein A-agarose beads (0.1 volume) were added.
Following rotation at 4°C for 1 h, the beads were washed succes-
sively with EB buffer containing 25 mM NaF, 1 mM Na3VO4, 0.1%
Nonidet P-40, and 1 ,uM okadaic acid (once); EB buffer containing 25
mM NaF, 1 mM Na3VO4, 0.1% Nonidet P-40 (twice); EB buffer
containing 25 mM NaF and 1 mM Na3VO4 (three times); and kinase
buffer (twice). All buffers contained protease inhibitors as indicated
above and ovalbumin (1 mg/ml final concentration). Finally, the
immunoisolated Weel was either used directly or frozen in liquid
nitrogen and stored at -80°C.
In Vitro Dephosphorylation of Hyperphosphorylated
Xenopus Weel Protein
Antibody beads containing hyperphosphorylated Weel protein
from M-phase extracts (see above) were washed successively in EB
buffer containing ovalbumin and protease inhibitors (once) and
phosphatase buffer (50mM Tris-HCl, pH 7.5,67 ,AM CaCl2, 1.34mM
NiCl2, 1 mg/ml ovalbumin; twice). The washed beads were then
agitated in the presence of 0.4 unit/ml human erythrocyte protein
phosphatase 2A (Upstate Biotechnology) in phosphatase buffer for
10 min at 21°C. Following this incubation, the phosphatase was
inactivated with okadaic acid (4 ,LM final concentration) and the
beads were washed with kinase buffer containing 1 mg/ml ovalbu-
min (twice). The phosphatase-treated Weel was immediately as-
sayed for kinase activity using the cyclin/Cdc2 substrate described
above.
In Vitro Translation of Xenopus Weel Protein
The pET3a-XeWeel vector was linearized with XhoI and capped
messenger RNA (mRNA) was prepared using T7 RNA polymerase
and the mCAP kit (Stratagene). Full-length Xenopus Weel protein
was translated from this synthetic mRNA in a rabbit reticulocyte
lysate (Promega) in the presence of Tran35S-Label (ICN Pharmaceu-
ticals, Covina, CA).
Miscellaneous Methods
Histone Hi kinase assays were performed as described in Dunphy
and Newport (1989). Phosphoamino acid analysis was carried out
according to standard procedures (Boyle et al., 1991). Protein con-
centrations were determined with the Bio-Rad protein assay kit.
Immunoblotting was performed as described previously (Coleman
et al., 1993) using "2I-labeled protein A (ICN) or "HI-labeled sheep
anti-mouse antibodies (Amersham, Arlington Heights, IL) except
that 3% bovine serum albumin and 10% heat-inactivated bovine
serum were used for the blocking agents for the anti-Xenopus Weel
peptide and MPM-2 antibodies, respectively. Quantification of both
HI and Weel kinase assays was performed using a PhosphorImager
(Molecular Dynamics, Sunnyvale, CA). Fluorography was per-
formed using Amplify (Amersham).
RESULTS
Isolation of a Xenopus Weel-like Kinase
To clone potential Xenopus Weel homologs, we uti-
lized two degenerate oligonucleotides to amplify seg-
ments of Xenopus oocyte cDNA in a PCR as described
in MATERIALS AND METHODS. These primers
were designed to anneal with conserved sequences in
catalytic subdomains VI and X of the Weel family
(e.g., fission yeast Weel and Mikl as well as human
Weel). PCR amplification yielded a -320-bp DNA
fragment encoding a protein sequence with significant
homology to the Weel class of protein kinases. This
fragment was then used to probe a Xenopus oocyte
library for the full-length cDNA. The full-length gene
for the Xenopus Weel-like kinase contains an open
reading frame of 555 amino acids corresponding to a
polypeptide with a predicted molecular mass of 62
kDa (Figure 1A; GenBank accession no. U13962). In
comparison with previously described members of the
Weel family, Xenopus Weel is most similar to the
human Weel-like kinase (Igarashi et al., 1991). The
Xenopus Weel protein is 71% identical in its catalytic
domain (Figure 1B) and 52% identical (68% similar)
over its full coding sequence to human Weel (N.
Watanabe, M. Broome, and T. Hunter, unpublished
observations). In addition, both the human and Xeno-
pus homologs contain a 19 amino acid insertion be-
tween catalytic subdomains VI and VII, and have a
less common ANE sequence (instead of APE) in sub-
domain VIII. The catalytic domain of Xenopus Weel is
also significantly related to the S. pombe Weel (35%
identity) (Russell and Nurse, 1987) and Mikl proteins
(32% identity) (Lundgren et al., 1991) as well as the
Saccharomyces cerevisiae Swel kinase (32% identity)
(Booher et al., 1993). Finally, all of these five members
of the Weel family share five residues (see asterisks in
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Figure 1. Sequence analysis
of a Xenopus Weel-like gene.
(A) Nucleotide and predicted
amino acid sequence of the
Xenopus Weel gene. Nudle-
otide sequence of a -2070-bp
ApaI to XhoI fragment is
shown. A predicted open
reading frame of 555 amino
acids is preceded by an in
frame termination codon
(TAA). The putative catalytic
domain of Xenopus Weel is
underlined. Roman numerals
denote the catalytic subdo-
mains found in eukaryotic
protein kinases (Hanks, 1991).
Ser/Thr-Pro motifs that are po-
tential phosphorylation sites for
a variety of mitotic kinases are
underlined. (B) Alignment and
comparison of the catalytic do-
mains of various Weel-like ki-
nases: Xenopus Weel (Xe-
Weel, residues 210-448),
Human Weel (Hu-Weel, resi-
dues 187-432), S. pombe Weel
(Sp-Weel, residues 560-786),
S. pombe Mikl (Sp-Mikl, resi-
dues 283-510), and S. cerevisiae
Weel, SWEl (Sc-Weel, resi-
dues 438-673). Identical resi-
dues shared between two or
more members of the Weel ki-
nase family are boxed. Aster-
isks designate amino acids
that are conserved between all
known members of the Weel
kinase family, but not in other
eukaryotic protein kinases.
Arrows indicate sequences
that were used to design de-
generate PCR primers. Se-
quence alignment was per-
formed by the SEQVAX
PILEUP program based on the
method of Feng and Doolittle
(1987).
A
-73 TGCAGGGAGTTGCAGTTACAGGATGTTTGTGGGAATGKCCTGTTGTTKATCCAGAGTTKCCCAGGTGTCGGCA
1M R T A ME C SEE L V OR L D FEE SGDE ESE LENS ERRI E GPOQKEGS P V
41 5 5 N R T N N C P F P I T P Q N N K R K L S P T 0 K L S P 5 5 D Y S P D P 5 V S
241 GTATCCGTCCCTCTAACCTGAAGTAGTTTAACCTTCCAAACTTGAAACCTCTTCGGCCCT
NE K K C P G S P L N S S T W K K L K L C D T P Y T P K S L L T K T L P 5 P G 5 R V
361 CCGAGGCAGCCTCTTGGCGACGGCGATGCACCCCGTATTACCTCCCTATCACAAACATCA
121 N C R G 0 R L L R F V K S T S A K L S S P 5 L V N S N P F T P K S S R 0 T N F 0
4KG
161
601
201
721
241
841
281
961
321
GENE
361
1201
401
P N G K R KENR PKE D D C NT S R Q M KY A E KE HNP A V F Q S K R F V L RE T
N M G SKRYEK T K F LEEI ER S G A GE F GES V FEKC V K RbL D G C F T A EKRR
SEEKP L A GS TEDE Q L A L R EV T ANK V L G KRH PRH V V R Y Y S A WAKE
ENH MESOQN EEYC N GEE LOG L E VEDN N EKE OQF V LEGQ E LK EEIL L Q
V EMSG L KYIHSEGE EGL V HME SEI PENSI FEI CR K 0 T EL GOQ EKE S E K
EEDL S SEGESV L YR EEGDL ENH V TEE L N P0Q V K KE G S R F LARNESI L 0
KEDY S 0 L P K AGE F ALEG LTDI A LA K G AKA P L P C N KEEN SN EIR K G
ATTCCCCGTCCAGTCTATCCGCTCTGCCTCCAGTGTGTCACAGCCGTTTAGCCCGGTCACATGCAGATTTTGT
441 N L P N V P Q L L T P V F L K L L K L L V N P D P V M R P P A K S L K K S S V L
1441
4KG1
1561
521
1681
1KEL
1921
B
Se-Weel
Ku-Keel
Op-Keel
Sp-MikE
SE-Keel
Se-Weel1
Hu-Weel
Sp-Keel
Op-MikE
ESc-Keel
Se-Keel
Ks-Keel
Op-Keel
Sp-MikE
OK-Keel
Se-Keel
Ks-Keel
Op-Keel1
Sp-MikE
GE-Keel
TTTTTTTATTATCTTATTGTCTTTTAAATAAAAATTTTAATGTGTAKAKAAAAAAAAAAAKAA
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Figure 1B) that are indicative of the Weel family, since
these residues are not commonly found in other ki-
nases (Hanks, 1991).
Xenopus Weel Phosphorylates Cdc2 on Tyrosine 15
in a Cyclin-dependent Manner
To establish the biochemical properties of Xenopus
Weel, we expressed a histidine-tagged version of
the protein in baculovirus-infected insect cells (Fig-
ure 2A). To assess whether the baculovirus-ex-
pressed Weel protein was catalytically active, we
first asked whether it was capable of autophosphor-
ylation. Upon incubation with [32pIATP, the puri-
fied Xenopus Weel protein became strongly radiola-
beled (Figure 2B). Phosphoamino acid analysis of
the labeled Weel protein revealed the presence of
mainly phosphotyrosine with a lesser amount of
phosphoserine (Figure 2C).
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Figure 2. Characterization of baculovirus-expressed Xenopus Weel
protein kinase. (A) Lysates from either uninfected Sf9 insect cells
(mock, lane 1) or cells infected with a Xenopus Weel-encoding
baculovirus (Weel, lane 2) were immunoblotted with anti-Xenopus
Weel peptide antibodies. (B) Purified recombinant Xenopus Weel
was incubated with [32P]ATP in vitro and processed for autoradiog-
raphy. (C) Phosphoamino acid analysis of 12P-labeled Xenopus Weel
protein from (B) shows that it is predominantly phosphorylated on
tyrosine (85%), with some labeling on serine (14%). S, phospho-
serine; T, phosphothreonine; Y, phosphotyrosine.
To ask whether the recombinant Weel would phos-
phorylate its presumed physiological target, we uti-
lized Cdc2 and cyclin B proteins that had been ex-
pressed in baculovirus-infected insect cells (A.
Kumagai and W. G. Dunphy, submitted). Routinely,
the Cdc2 and cyclin proteins were produced sepa-
rately in insect cells. Next, the cyclin protein was
purified on nickel-agarose by virtue of a six-histidine
tag that had been engineered into its coding sequence.
The cyclin-coated agarose beads were then added to
Cdc2-containing insect cell lysates, and the resulting
Cdc2-cyclin complex was isolated as described (A.
Kumagai and W. G. Dunphy, unpublished data) (see
MATERIALS AND METHODS). In some cases, the
cyclin and Cdc2 proteins were purified separately be-
fore addition to the kinase assay (see MATERIALS
AND METHODS). As shown in Figure 3A (lane 4), the
incubation of the Cdc2/cyclin B complex with recom-
binant Xenopus Weel protein results in efficient ty-
rosine phosphorylation of the Cdc2 subunit. In this
experiment, the tyrosine phosphorylation of Cdc2 was
monitored by immunoblotting with anti-phosphoty-
rosine antibodies. As expected, no tyrosine phosphor-
ylation of Cdc2 was detected if either the Cdc2 or
C
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Figure 3. Xenopus Weel phosphorylates Cdc2 exclusively on ty-
rosine in a cycin-dependent manner. (A) Purified recombinant
proteins: Xenopus Weel (Weel, lanes 1, 2, and 4), human cyclin B1
(cyclin, lanes 1, 3, and 4), and Xenopus wild-type Cdc2 (Cdc2, lanes
2, 3, and 4) were incubated in the presence of an ATP-regenerating
system (see MATERIALS AND METHODS) and processed for im-
munoblotting using either anti-cyclin (top panel), anti-Cdc2 (middle
panel), or anti-phosphotyrosine (bottom panel) antibodies. (B) Pu-
rified recombinant proteins: a complex of human cyclin B1 and
Xenopus T161A kinase-negative Cdc2 (cyclin/Cdc2; lanes 1 and 3)
and Xenopus Weel (Weel; lanes 2 and 3) were incubated in the
presence of [32PJATP. Following a 20 min incubation at 21'C, sam-
ples were electrophoresed and processed for autoradiography. (C)
Phosphoamino acid analysis of Cdc2 from (B) shows that Xenopus
Weel phosphorylates Cdc2 exclusively on tyrosine. S, phospho-
serine; T, phosphothreonine; Y, phosphotyrosine.
Weel protein was omitted from the incubation (Figure
3A, lanes 1 and 3). Significantly, there was also no
Weel-catalyzed phosphorylation of Cdc2 if purified
Cdc2 alone instead of the Cdc2/cyclin B complex, was
employed as the substrate (Figure 3A, lane 2). This
observation demonstrates that the recognition of Cdc2
by Xenopus Weel in vitro is cyclin-dependent, which is
consistent with earlier experiments indicating that
Cdc2 does not become tyrosine phosphorylated in
cycloheximide-treated Xenopus egg extracts that lack
cyclin B (Solomon et al., 1990; Kumagai and Dunphy,
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1991; Parker et al., 1991). Interestingly, the kinase ac-
tivity of Xenopus Weel is highly thermolabile: the
protein loses essentially all of its activity upon a 10-
min incubation at 36°C (our unpublished observa-
tion). This thermal instability may reflect the fact that
Xenopus is a cold-blooded organism.
To assess whether Xenopus Weel would phosphor-
ylate Cdc2 solely on tyrosine, we treated the Cdc2/
cyclin complex with Weel protein in the presence of[32PIATP, and then subjected the resulting labeled
Cdc2 protein to phosphoamino acid analysis (Figure 3,
B and C). A technical consideration is that we used a
kinase-inactive version of Cdc2 (the T161A mutant
that cannot be phosphorylated at a site required for
catalytic activity) to reduce the potential background
incorporation of serine and threonine that might result
from the presence of highly active Cdc2 protein ki-
nase. Control experiments in which tyrosine phos-
phorylation of Cdc2 was measured with anti-phos-
photyrosine antibodies indicated that Xenopus Weel
phosphorylated wild-type and T161A mutant Cdc2
equally well (see Figure 4). Quantitation of the data
from the phosphoamino acid analysis (Figure 3C) in-
dicated that 99% of the radioactive phosphate was
present in phosphotyrosine. Thus, Xenopus Weel, like
the human Weel homolog, phosphorylates Cdc2 only
on tyrosine and apparently not on threonine residues
such as Thr-14 (Parker and Piwnica-Worms, 1992;
McGowan and Russell, 1993).
To establish whether the tyrosine phosphorylation
of Cdc2 occurred only on the physiologically relevant
site (Tyr-15), we repeated the Weel assays using a
variety of Cdc2 mutants as the kinase substrates (Fig-
ure 4). Specifically, we utilized the Cdc2 Y15F mutant
that cannot be phosphorylated on Tyr-15 as well as the
T161A and T14A mutant forms of Cdc2. As shown in
Figure 4A, in experiments where both the T161A mu-
tant and wild-type versions of Cdc2 were efficiently
phosphorylated on tyrosine by Weel (Figure 4A, lanes
1-4 and 5-8), there was no detectable tyrosine phos-
phorylation of the Y15F mutant (Figure 4A, lanes
9-12). In similar experiments, the T14A mutant also
was phosphorylated efficiently by Weel, as might be
expected (not shown). Taken together, these results
indicate that Xenopus Weel phosphorylates Cdc2 only
on tyrosine 15, and that recognition of Cdc2 by Weel
is not appreciably dependent upon prior phosphory-
lation of either the threonine 161 or threonine 14 res-
idues. Importantly, the tyrosine phosphorylation of
wild-type Cdc2 also resulted in a substantial reduction
of its activity as a histone Hi kinase (Figure 4B, middle
columns). As expected, the Y15F mutant that had been
treated with Weel showed no diminution in Hi ki-
nase activity (Figure 4B, right columns), while the
Weel-treated T161A mutant was inactive as an Hi
kinase whether or not it had been phosphorylated by
Weel (Figure 4B, left columns).
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Figure 4. Xenopus Weel phosphorylates Cdc2 specifically on ty-
rosine 15 resulting in a decrease in the HI kinase activity of the
modified Cdc2/cyclin complex. (A) Purified recombinant human
cyclin BI bound to various forms of Xenopus Cdc2 (T161A, threo-
nine 161 mutated to alanine, lanes 1-4; wild type, lanes 5-8; Y15F,
tyrosine 15 mutated to phenylalanine, lanes 9-12) was used in in
vitro kinase assays (see MATERIALS AND METHODS) that con-
tained either control buffer (lanes 1, 2, 5, 6, 9, and 10) or purified
Xenopus Weel (+Weel, lanes 3, 4, 7, 8, 11, and 12). The samples were
processed for immunoblotting with either anti-phosphotyrosine
(top panel) or anti-Cdc2 (bottom panel) antibodies. (B) Cdc2-asso-
ciated HI kinase activity of the samples shown in part (A) in the
presence (stripped bars) or absence (clear bars) of Xenopus Weel. As
expected, Xenopus Weel-modified wild type Cdc2 loses much of its
kinase activity (-30% of control-treated). In contrast, the Hi kinase
activity of both the T161A form (which is inactive as a kinase) and
the Y15F form (which lacks the only residue Xenopus Weel phos-
phorylates) were unchanged by incubation with Xenopus Weel (see
text).
Exogenously Added Xenopus Weel-like Kinase
Causes a Mitotic Delay in Egg Extracts
In fission yeast, the length of the G2 phase is directly
correlated with the intracellular concentration of the
Weel protein such that overexpression of Weel leads
to a mitotic delay and inactivation of Weel leads to a
shortening of the G2 phase (Nurse, 1975; Russell and
Nurse, 1987). To ask whether the concentration of the
Xenopus Weel protein could influence the length of
the cell cycle, we added varying amounts of exoge-
nous Weel protein to cell cycle extracts from Xenopus
eggs (Figure 5, A and B). We observed that the recom-
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Figure 5. Xenopus Weel causes a dose-dependent mitotic delay in
frog egg extracts and a concomitant increase in the phosphotyrosine
content of Cdc2. (A) CSF-arrested Xenopus egg extracts were acti-
vated with CaCl2 and incubated at 21°C. At t = 20 min, 0.2 volume
of either control buffer (circles) or purified Xenopus Weel (squares)
was added. At the indicated times, aliquots were removed and
assessed for nuclear envelope breakdown (NEB) by visualizing with
phase contrast microscopy and Hoechst staining. (B) Plot of mitotic
delay (time difference of half-maximal NEB) between the control or
Weel-treated extracts vs. the added concentration of exogenous
Weel protein. (C) Aliquots were taken from the incubation shown
in part A at the indicated times (30-120 min). Endogenous Cdc2 was
isolated with p13-agarose beads and subjected to immunoblotting
with either anti-phosphotyrosine (top panel) or anti-Cdc2 (bottom
panel) antibodies. In the control samples (lanes 1-5), Cdc2 under-
goes tyrosine dephosphorylation between 75 and 90 min, the time at
which the extract entered mitosis (part A). In contrast, the Weel-
treated extract (lanes 6-10) contains tyrosine phosphorylated Cdc2
for a prolonged period (>120 min), consistent with a delay in
mitotic entry (part A).
binant Xenopus Weel protein elicited a dose-depen-
dent delay of the entry into mitosis (Figure 5B). At the
highest concentration of added Weel protein (3 ng/
,ul), there was a -30 min delay in the time required for
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the extracts to enter mitosis, as judged by visual mon-
itoring of nuclear disassembly. In these experiments, it
was important to know the concentration of the endo-
genous Weel protein in the egg extracts. Using anti-
Xenopus Weel antibodies and known amounts of bac-
terially expressed Xenopus Weel protein (see
MATERIALS AND METHODS), we estimated that the
endogenous level of the Weel protein is -1 ng/ul.
Thus, the addition of a relatively modest amount of
extra Weel protein (3-fold) has a significant effect on
cell cycle progression.
To examine whether the Weel-induced delay of mi-
tosis in Xenopus extracts could be attributed to the
increased tyrosine phosphorylation of Cdc2, we exam-
ined the phosphotyrosine content of Cdc2 at succes-
sive intervals during the cell cycle in the presence and
absence of exogenous Weel protein (Figure 5C). In the
control incubation, the tyrosine phosphorylation of
Cdc2 peaked at 75 min post-activation and then
abruptly declined to low levels at 90 min (Figure 5C,
lanes 1-5), the time by which the extract had entered
mitosis. In contrast, the phosphotyrosine content of
Cdc2 in the extract containing added Weel protein
was discernibly elevated and remained high for ap-
proximately 30 min longer (Figure 5C, lanes 6-10). In
control experiments, we established that the Weel-
induced delay of the cell cycle could be abolished by
the addition of okadaic acid (3 ,uM), demonstrating
that the mitotic delay was not due to a non-specific
effect upon the extract. Collectively, these results in-
dicate that Xenopus Weel, like the fission yeast Weel
kinase, can modulate the length of interphase in a
concentration-dependent manner.
Xenopus Weel Activity Is Highly Regulated During
the Cell Cycle
Having established the basic properties of Xenopus
Weel, we next asked whether this enzyme is regulated
during the cell cycle. To pursue this objective, we first
prepared either interphase or M phase (CSF-arrested)
extracts from Xenopus eggs. To arrest the extracts in
interphase, we utilized either cycloheximide (which
blocks cyclin synthesis) or aphidicolin (which imposes
the replication checkpoint provided that there is a
sufficiently high concentration of exogenously added
DNA in the extract) (Dasso and Newport, 1990). Al-
ternatively, interphase extracts without these inhibi-
tory agents could be collected 50 min after activation
with Ca2 , well before the rise of MPF activity. After
immunoprecipitation and immunoblotting of the var-
ious extracts with anti-Weel peptide antibodies, we
observed that the electrophoretic mobility of Weel
varied greatly during the cell cycle (Figure 6A). Spe-
cifically, the Weel protein from interphase extracts
migrated as a 68-kDa species during SDS-gel electro-
phoresis irrespective of whether the extract had been
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Figure 6. Xenopus Weel is localized in the
cytosol and differentially modified during the A '4* B
cell cycle. (A) Endogenous Xenopus Weel was c qi '1Z.
immunoprecipitated with anti-Xenopus Weel -o M "r total cyto. memb.
peptide antibodies from a CSF-arrested Xeno- R < Q R
pus egg extract (M-phase, lane 2), an inter- I M I M I M I
phase extract (I-Phase) that had been acti-
vated in the presence (lane 1) or absence (lane aXe-Weel -75kD
3) of cycloheximide, or an S phase-blocked * 68 kD
extract (Aphidicolin + 1000 nuclei, lane 4).
Following immunoprecipitation, the samples
were immunoblotted with anti-Xenopus Weel
antibodies. The apparent molecular weights axcdc2
of the interphase and mitotic forms of Xeno- 75 kD ^ A
pus Weel (68 and 75 kDa, respectively) are * kDindicated. (B) Total cytoplasm (lanes l and 2), _ kD 1 2 3 4 5 6
the cytosol fraction (lanes 3 and 4), or the
membrane fraction (lanes 5 and 6) were pre-
pared from either CSF-arrested (M; lanes 1, 3, C
and 5) or interphase (I; lanes 2, 4, and 6)
extracts as described in MATERIALS AND
METHODS. The fractions were subjected to %NEB 0 0 16 100lo100
immunoprecipitation with anti-Weel peptide Time 30' 60' 75' 90' 120'
antibodies and then processed for immunob-
lotting with either anti-Xenopus Weel (top
panel) or anti-Cdc2 (bottom panel) antibod- g J*M Xe-Weelies. Note that Xenopus Weel is found in the
cytosol fraction during both M phase and in-
terphase, but is associated with Cdc2 only 1 2 3 4 1 2 3 4 5
duringM phase. (C) A CSF-arrested Xenopus egg extract was activated by addition of CaCl2 and aliquots were removed at the indicated times.
These aliquots were bound to p13-agarose beads, washed, and processed for immunoblotting using anti-Xenopus Weel antibodies.
treated with cycloheximide, no drug, or aphidicolin
(Figure 6A, lanes 1, 3, and 4). However, the M phase
form of Weel in CSF extracts was noticeably greater in
molecular mass with an electrophoretic mobility cor-
responding to 75 kDa (Figure 6A, lane 2). As described
in greater detail below, this mobility shift is attribut-
able entirely to phosphorylation. Upon fractionation
of the egg extracts into a soluble and membrane frac-
tion by ultracentrifugation, we observed that both the
68- and 75-kDa forms of Xenopus Weel were present
almost exclusively (>90% of total) in the soluble frac-
tion (Figure 6B).
In the course of examining the phosphorylation state
of Weel during the cell cycle, we observed that the
Cdc2 protein could be found in a complex with Weel
in a cell cycle dependent manner. Specifically, immu-
noblotting of anti-Weel immunoprecipitates with an-
ti-Cdc2 antibodies revealed the specific association of
Cdc2 with Weel in M phase extracts but not inter-
phase-arrested extracts (Figure 6B, bottom panel, com-
pare lanes 1 and 3 with lanes 2 and 4). In time-course
experiments with cycling extracts (Figure 6C), we ob-
served that the endogenous Weel protein also could
be bound to p13-agarose beads (an affinity absorbent
for Cdc2 and associated proteins) depending upon the
state of phosphorylation of the Weel protein. Specifi-
cally, there was no binding to p13-agarose beads by
the 68-kDa, underphosphorylated form of Weel from
extracts early in the cell cycle (<60 min post-activa-
tion). However, between 75 and 120 min post-activa-
tion, there was a preferential association of hyper-
phosphorylated Weel with p13-agarose which
coincided with the timing of nuclear envelope break-
down in the extract (Figure 6C, lanes 3-5). Greater
than 75% of the Weel protein from M phase extracts
bound specifically to p13-agarose beads in these ex-
periments (our unpublished observation).
Next, we examined whether the activity of Xenopus
Weel would vary in a cell-cycle dependent manner.
To measure the kinase activity of Weel, we utilized
any one of three procedures (Figure 7). For example,
we could detect Weel-dependent tyrosine phosphor-
ylation of Cdc2 by measuring either its reactivity with
anti-phosphotyrosine antibodies (Figure 7A) or its in-
corporation of 32p from radioactive ATP (Figure 7C).
Alternatively, the kinase activity of Weel could be
assessed on the basis of its ability to phosphorylate
itself in the presence of radioactive ATP (Figure 7B).
By all three assay methods, we observed a large
difference in kinase activity between the 68- and 75-
kDa forms of Xenopus Weel. The 68-kDa interphase
form of Weel was highly active (Figure 7A, lanes 5-8;
Figure 7B, lane 2; and Figure 7C, lane 3), as might be
expected for an enzyme that serves to shut off Cdc2
during this phase of the cell cycle. In contrast, the
75-kDa mitosis-specific form of Weel showed little if
any ability to phosphorylate either Cdc2 or itself in the
various kinase assays (Figure 7A, lanes 3 and 4; Figure
7B, lane 1; and Figure 7C, lane 2). Quantitation of the
various assays performed indicated that the 68-kDa
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A B Figure 7. Xenopus Weel activity is regulated
M I during the cell cycle by its phosphorylation
b state. (A) Endogenous Xenopus Weel was im-
+Xe-Weel munoprecipitated from a CSF-arrested Xeno-
pus egg extract (M, lanes 3 and 4), an inter-M I I A phase extract that had been activated in the
presence (I, lanes 5 and 6) or absence (I, lanes
7 and 8) of cycloheximide, or an S-phase
@i blocked extract (A, lanes 9 and 10) that had
_ _ _ _ _ _UI~E~44Im -Cdc2-Y* been treated with aphidicolin in the presence
of 1000 sperm nuclei per ,ul. The kinase activ-
ity of each of these immunoprecipitates was
then measured in vitro using a purified re-
combinant cyclin/Cdc2 substrate in the pres-
ence of an ATP regenerating system as de-
aG:
-
.*iF^-cdc2 scribed in Figure 3. The reaction products
were immunoblotted and probed with either
anti-phosphotyrosine (top panel) or anti-Cdc2
(bottom panel) antibodies. The same Xenopus
1 2 3 4 5 6 7 8 9 10 1 2 Weel immunoprecipitates used in this exper-iment were also immunoblotted for Xenopus
Weel in Figure 6. Note that equivalent
amounts of Xenopus Weel are present in all of
rD the samples as judged by immunoblotting
with anti-Xenopus Weel antibodies (see Fig-
V j '; ure 6A). (B) Auto-kinase activity of Xenopus
EoRQ Weel. Xenopus Weel was immunoprecipi-
' Xe-Weel tated from a CSF-arrested (M, lane 1) or an
AE) interphase (I, lane 2) Xenopus egg extract andMI
Xe-Weel incubated with [32P]ATP and processed for
aXe-Weel
- Xe-Weel autoradiography. (C) Recombinant humane- ecyclin Bl/Xenopus T161A kinase-negative
Cdc2 substrate (cyc/Cdc2) was incubated
with [32P]ATP in the absence (lane 1) or pres-
ence (+Xe-Weel, lanes 2-4) of endogenous
Xenopus Weel which had previously been im-
munoisolated from either a CSF-arrested (M,
lane 2), interphase (I, lane 3), or S-phase ar-
- Xe-Weel rested (A, Aphidicolin plus 2000 nuclei per ul,
lane 4) Xenopus egg extract. The migration of
JcyclIin ~ )Jcyc Iin phosphorylated Xenopus Weel (Xe-Weel),
human cyclin Bl (cyclin) and Xenopus Cdc2
(Cdc2) have been indicated. (D) In vitro de-
phosphorylation of the modified Xenopus
Weel protein restores its kinase activity. Im-
munoisolated mitotic Xenopus Weel protein
(lanes 2 and 3) was treated with phosphatase
_b_inh -cdc2
-cdc2 buffer alone (mock, lane 2) or with the same
buffer containing purified erythrocyte phos-
phatase 2A (PP2A, lane 3). After treatment with
okadaic acid and subsequent washing, the sam-
1 2 3 4 1 2 3 ples were either immunoblotted using anti-Xe-
nopus Weel antibodies (top panel) or assayed
for Weel activity in the presence of cyclin/Cdc2 substrate and (32P]ATP (bottom panel). The positions of phosphorylated and unphosphorylated
Xenopus Weel (top panel) as well as cycin and Cdc2 (bottom panel) have been indicated. Lane l depicts the Cdc2/cyclin complex incubated
without added Weel protein.
form of Weel was 7-20-fold more active than the Consistent with this observation, we observed that
75-kDa form. Finally, we demonstrated that the re- treatment of Xenopus interphase egg extracts with oka-
duced kinase activity of the 75-kDa mitotic version of daic acid (3 ,tM) resulted in the rapid phosphorylation
Weel was indeed due to phosphorylation. Specifi- of Weel (our unpublished observation).
cally, we found that treatment of the 75-kDa form of These experiments establish that Weel activity is high
Xenopus Weel with protein phosphatase 2A (PP2A) during interphase and low during mitosis, but it is also
could both reverse the mobility shift back to 68 kDa important to ask whether the activity of Weel might be(Figure 7D, top panel) and restore the ability of Weel modulated during interphase by parameters that would
to phosphorylate Cdc2 (Figure 7D, bottom panel). be expected to contribute to the various checkpoints that
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operate during the cell cycle. In the Xenopus egg system,
it has been possible to reconstitute the replication check-
point in vitro by the addition of DNA synthesis inhibi-
tors (e.g., aphidicolin) to extracts containing greater than
several hundred nuclear equivalents of DNA per ,ul of
egg lysate (Dasso and Newport, 1990).
To examine whether the activity of the Xenopus Weel
homolog described in this study might be modulated
directly by the replication checkpoint, we immunopre-
cipitated Weel from interphase extracts prepared in the
presence or absence of aphidicolin and 1000 demem-
branated Xenopus sperm nuclei per ,ul of egg extract. We
consistently observed that neither the electrophoretic
mobility (Figure 6A, lane 4) nor the kinase activity (Fig-
ure 7A, lanes 9 and 10; Figure 7C, lane 4) of this Xenopus
Wee-like kinase was significantly altered by the presence
of aphidicolin. Taken together, these results indicate that
the activity of the particular Weel homolog examined in
these studies is not affected by the imposition of the
replication checkpoint, even though the extracts from
which this Weel protein had been immunoprecipitated
remain efficiently blocked in interphase due to the pres-
ence of unreplicated DNA.
Cdc2 and an Additional Kinase Phosphorylate Weel
at Mitosis
The above experiments indicate that the Xenopus Weel
protein becomes down-regulated at mitosis due to the
action of one or more protein kinases that shift its
electrophoretic mobility from 68 to 75 kDa. To address
the identity of the Weel-inhibitory kinase(s), we car-
ried out a number of experiments. One line of exper-
imentation involved the use of a monoclonal antibody
(MPM-2) that recognizes a myriad of mitotic phospho-
proteins (known as MPM-2 antigens) in a wide variety
of cell types. The enzyme(s) responsible for the gen-
eration of the MPM-2 epitope at mitosis is known as
the ME kinase (Kuang et al., 1994). To address the
possibility that the Weel protein might be an MPM-2
antigen, we subjected Weel protein that had been
immunoprecipitated from Xenopus extracts to immu-
noblotting with MPM-2 antibodies. As shown in Fig-
ure 8A, the mitotic form of Weel (75 kDa) reacted
strongly with MPM-2 antibodies (lane 2), but the 68
kDa form of Weel in interphase-arrested extracts dis-
played no MPM-2 reactivity (lanes 1, 3, and 4). In
parallel, we examined whether the recombinant fis-
sion yeast Weel protein that had been introduced into
Xenopus egg extracts could also become an MPM-2
antigen (Figure 8B). Consistent with the observa-
tions on the endogenous Xenopus protein, the exog-
enous fission yeast Weel protein that had been re-
isolated from mitotic egg extracts reacted well with
the MPM-2 antibodies (Figure 8B, lane 1), whereas
the form incubated in interphase extracts did not
(Figure 8B, lane 2).
A number of studies have suggested that the ME
kinase is distinct from the Cdc2 kinase (Kuang et al.,
1991, 1994; Kuang and Ashorn, 1993). However, the
consensus sequences for phosphorylation by the ME
or Cdc2 kinases both share the property of containing
either Ser-Pro or Thr-Pro as part of the recognition
motif (Westendorf et al., 1994). The amino acid se-
quence of Xenopus Weel contains at least two stretches
that correspond well to the consensus sequence for
recognition by the ME kinase (see DISCUSSION), but
one of these sites also resembles a potential Cdc2
phosphorylation site. In addition, there are a total of
11 Ser-Pro or Thr-Pro motifs throughout the Xenopus
Weel sequence (Figure 1A).
To examine whether Weel could serve as a substrate
for Cdc2, we incubated the active Cdc2/cyclin B com-
plex in the presence of recombinant Weel protein
(Figure 8). As shown in Figure 8C (bottom panel), the
Weel protein became readily phosphorylated in the
presence of active Cdc2 protein kinase, as evidenced
by an upward mobility shift during gel electrophore-
sis (lanes 2, 4, and 6). Interestingly, the shifted form of
Weel that had been phosphorylated by Cdc2 also
became reactive with MPM-2 antibodies (see lanes 2,
4, and 6 in the top panel of Figure 8C).
To ask whether the shifted form of Weel that had
been phosphorylated by Cdc2 in vitro had altered
kinase activity, we immunoprecipitated Weel after it
had been incubated with either active Cdc2/cyclin B
or kinase-negative Cdc2T161A/cyclin B, and then as-
sayed its ability to phosphorylate Cdc2 in a second
incubation (Figure 8D). We found that Weel that had
been phosphorylated previously by Cdc2 in vitro
showed a greatly reduced ability to phosphorylate
Cdc2 in a subsequent kinase assay (Figure 8D, lane 1),
whereas Weel that had been previously incubated
with inactive Cdc2 (lane 2) or buffer alone (lane 3) was
fully active.
The above experiments establish that Weel is a sub-
strate for Cdc2 kinase in vitro. To shed light on the
contribution of Cdc2 to Weel regulation in vivo, we
asked whether Xenopus extracts that lack active Cdc2
protein would retain any Weel-specific kinase activ-
ity. For this purpose, we applied M phase extracts
from Xenopus eggs to p13-agarose, a chromatography
resin that efficiently removes Cdc2 and associated pro-
teins (Dunphy et al., 1988). Repeated chromatography
of the M phase extracts on p13-agarose resulted in the
essentially quantitative depletion of the Cdc2 protein
(99% removal; see Figure 9C). We then added 35S-
labeled Xenopus Weel protein to either Cdc2-depleted
extracts or control extracts that had been subjected to
the same protocol with agarose beads lacking p13. We
observed that the 35S-labeled Weel protein in the con-
trol extracts was phosphorylated efficiently, consistent
with the results described above (Figure 9A, top and
middle panels; Figure 9B, see lanes 1 and 2). Interest-
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ingly, the Weel protein became phosphorylated at a
similar rate in the Cdc2-depleted extract, but its elec-
trophoretic mobility ultimately reached a plateau that
was intermediate between that of the interphase and
mitotic forms of Weel (Figure 9A, bottom panel; Fig-
ure 9B, lane 3), even after a 4 h incubation (unpub-
lished observation). This observation indicates that
Cdc2 is only partially responsible for the phosphory-
lation of Weel at mitosis, and that a distinct kinase
also phosphorylates Weel at mitosis.
DISCUSSION
The main objective of this study was to examine the
biochemical mechanisms underlying the regulation of
Cdc2-specific tyrosine kinase activity in Xenopus egg
extracts. In this system, the tyrosine phosphorylation
of Cdc2 appears to be a major rate-limiting parameter
19:3 Figure 8. The Weel protein becomes an
MPM-2 antigen at M phase, and is inactivated
by in vitro treatment with active Cdc2/cyclin
B. (A) Endogenous Xenopus Weel was immu-
-@-Sp-We noprecipitated from a CSF-arrested Xenopus
_00- Sp-Weel egg extract (M-Phase, lane 2), an interphase
extract (I-Phase) that had been activated in the
presence (lane 1) or absence (lane 3) of cyclo-
heximide, or an S phase-blocked extract
(Aphidicolin + 1000 nuclei, lane 4). These
samples were then immunoblotted and
probed with either MPM-2 antibodies (top) or
-q*-Sp-Wee1 anti-Xenopus Weel antibodies (bottom). (B)
Purified, histidine-tagged S. pombe Weel pro-
m
-_-Sp-Weel tein was added to either a CSF-arrested (M-
phase, lane 1) or an interphase (I-phase, lane 2)
Xenopus egg extract, incubated for 10 min, and
then re-isolated on nickel-IDA beads. These
samples were then washed, immunoblotted,
and probed with either MPM-2 antibodies
(top panel) or anti-S. pombe Weel antibodies
(bottom panel). (C) Active Cdc2/cyclin B can
phosphorylate recombinant Xenopus Weel
J and convert it to an MPM-2 antigen. Follow-
'O' ing an in vitro kinase reaction performed in
the presence (lanes 2, 4, 6, and 7) or absence
A& § (lanes 1, 3, and 5) of wild type Cdc2/cyclin B
e ci complex, recombinant Xenopus Weel (1 x = 10
asO0t ~ngproteinperassay),wasprocessedforimmuno-4 t e blotting using either anti-MPM-2 (top panel)
or anti-Xenopus Weel (bottom panel) antibod-
ies. (D) Xenopus Weel is inactivated due to
(i) phosphorylation by Cdc2/cyclin B. Xenopus
4 -cdc2-Y Weel protein was treated with wild-type
Cdc2/cycin B (lane 1), Cdc2T161A/cyclin B
(lane 2), or buffer alone (lane 3). Following the
incubation, the Weel protein was immunopre-
cipitated and then assayed for the ability to
mm _ - cdc2 phosphorylate Cdc2 as described in Figure 7A.
Following the kinase assay, phosphorylation
of Cdc2 was assessed with anti-phosphoty-
rosine antibodies (top panel) or anti-Cdc2 an-
1 2 3 tibodies (bottom panel).
controlling the entry into mitosis (Solomon et al., 1990;
Kumagai and Dunphy, 1991; Smythe and Newport,
1992; Lee et al., 1994). Thus, the elucidation of how the
Cdc2-specific tyrosine kinase (Weel) and Cdc2-spe-
cific tyrosine phosphatase (Cdc25) activities are con-
trolled at the molecular level will be necessary for a
full understanding of mitotic initiation.
To pursue this goal, we isolated the gene for a
Xenopus Weel-like kinase. We established that this
kinase possesses many characteristics of a Weel fam-
ily member. First, the Xenopus Weel protein efficiently
phosphorylates Cdc2 on tyrosine 15 in a manner that
is completely dependent upon its association with
cyclin. Second, this tyrosine phosphorylation of Cdc2
results in a substantial reduction of its kinase activity
toward histone Hi. Third, the elevation of Weel ki-
nase levels in Xenopus egg extracts by the addition of
recombinant Weel protein results in a readily observ-
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Figure 9. The Xenopus Weel protein is only partiall
mitotic extracts which lack active Cdc2/cyclin com
labeled full-length Xenopus Weel was mixed with CS
panel, lanes 4-12), control agarose-depleted CSF c
depleted, middle panel, lanes 4-12), or p13-agarose
cytosol (Cdc2 depleted, bottom panel, lanes 4-12).
control lanes 1 and 2 show the migration of Xenopu
total CSF extract at 0 and 60 min, respectively. Sam
moved for electrophoresis and fluorography at the ini
In lane 3, the starting (S) 35S-labeled Xenopus Weel ha
for reference. Hatch marks denote unphosphoryl
mark), fully phosphorylated (top mark), and partiall
lated (middle mark) forms of the Weel protein. O
full-length Xenopus Weel protein was mixed with CS
tosol, lane 1), control agarose-depleted CSF cytosol (m
lane 2), or p13-agarose depleted CSF cytosol (Cdc2-dej
Samples were removed for electrophoresis and fluor
min. In lane 4, the starting 35S-labeled Xenopus W
loaded for reference. (C) The Cdc2 protein from C
quantitatively depleted (>99% removal) by p13-agaro
raphy. The CSF cytosol from part (A) was immun
anti-Cdc2 antibodies following treatment with eithe
beads (lane 1) or control-agarose beads (lane 2).
able delay of the entry into mitosis. Finally
pus Weel protein can be found in a comple
at mitosis, suggesting a biochemical inte
tween the two proteins.
Next, we examined the regulation of ti
and found that the activity of Xenopus We(
a manner consistent with its role as a neg
lator of mitosis: its activity is high during
when it should suppress Cdc2, and low dui
when Cdc2 must be active. The Weel-like
we have identified is present in constar
throughout the first embryonic cell cycle
but undergoes a large variation in kinase a
ing this period. This oscillation is accon
substantial changes in the phosphorylation state of
Xenopus Weel. Specifically, the interphase form of
0' 60' 0o Weel (68 kDa) is highly active and does not appear to
0 _ - be extensively phosphorylated, as judged by its mo-
- bility during SDS-gel electrophoresis. In contrast, the
mitotic form of Weel (75 kDa) is heavily phosphory-
- lated and essentially inactive. The inability of the mi-
totic form of Weel to phosphorylate Cdc2 is a direct
P4_ consequence of phosphorylation, since the protein can
D 11 12 be reactivated by in vitro treatment with PP2A.
These experiments directly substantiate the exis-
tence of two types of Weel-regulatory factors: a Weel
inhibitory kinase(s) and a Weel-stimulatory phos-
phatase(s). A variety of arguments suggest that the
Zt2t stimulatory phosphatase that keeps Xenopus Weel ac-
tive during interphase corresponds to a form of pro-
tein phosphatase 2A. In this study, we have found that
this Weel-stimulatory phosphatase activity is highly
_~ ]cdC2 sensitive to okadaic acid. Moreover, purified protein
phosphatase 2A is very effective in reversing the
2 inhibitory phosphorylation of Weel in vitro. The in-
volvement of PP2A in the up-regulation of Weel, com-
ly modified in bined with its well established role in the down-reg-
F cytosol (top ulation of Cdc25 (Kumagai and Dunphy, 1992; Izumi
-ytosol (mock et al., 1992; Clarke et al., 1993; Lee et al., 1994), provides
depleted CSF a logical mechanism for the coordinate regulation of
For reference, the enzymes involved in the tyrosine phosphorylation
s Weel in the and dephosphorylation of Cdc2 [reviewed in Dunphyiples were re- (1994)].
s been loaded Another important issue that we have addressed
lated (bottom involves the identity of the Weel inhibitory kinase(s)
y) p3hospabely that shut off Weel during mitosis. The Xenopus Weel
iF cytosol (cy- coding sequence contains eleven Ser-Pro (SP) or Thr-
iock-depleted, Pro (TP) motifs that are found in the consensus recog-
pleted, lane 3). nition site for a number of mitotic kinases, including
ography at 60 the Cdc2, MAP, and ME kinases (Nigg, 1991; Thomas,
SF cytosol is 1992; Westendorf, 1994). Interestingly, ten of these
se chromatog- SP/TP motifs are found in the N-terminal one-third of
oblotted with Xenopus Weel outside of the area that comprises the
r p13-agarose catalytic domain of the kinase. A high concentration of
SP/TP motifs in the N-terminal region is a character-
istic shared with Weel proteins from other species,
r, the Xeno- including fission yeast, budding yeast, and humans
(with Cdc2 (Russell and Nurse, 1987; Booher et al., 1993; N. Wa-
raction be- tanabe, M. Broome, and T. Hunter, unpublished ob-
servations). In the case of the fission yeast protein, this
his enzyme N-terminal region was shown to be phosphorylated
el varies in selectively in mitotic Xenopus egg extracts (Tang et al.,
,ative regu- 1993). A plausible model is that the N-terminal do-
interphase main comprises a regulatory domain whose phos-
ring mitosis phorylation at mitosis inhibits the capacity of Weel to
kinase that act as a kinase and/or recognize Cdc2. Interestingly,
it amounts we have found in this study that the M phase form of
in Xenopus, Weel cannot phosphorylate either itself or Cdc2, sug-
Lctivity dur- gesting that the catalytic mechanism of Weel has been
nipanied by impeded.
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In addressing the identity of the Weel-inhibitory
kinases, we undertook a number of complementary
approaches. In the most direct experiment, we asked
whether highly active Cdc2/cyclin B would be able to
phosphorylate the Xenopus Weel protein in a cell-free
reaction. These studies demonstrated that Cdc2/cy-
clin B could phosphorylate Weel very efficiently, and
that this phosphorylation resulted in a strong inacti-
vation of Weel kinase activity. The involvement of
Cdc2 in down-regulating Weel provides direct evi-
dence for an autocatalytic or self-perpetuating feed-
back loop in which limited amounts of active Cdc2 can
trigger the full activation of Cdc2/cyclin B (MPF) at
mitosis (Solomon et al., 1990; Kumagai and Dunphy,
1992; Izumi et al., 1992; Smythe and Newport, 1992;
Hoffmann et al., 1993; Lee et al., 1994). The biochemical
events that lead to the initial triggering of this feed-
back circuit remain to be elucidated. In particular, it is
not clear how the small amount of active Cdc2 that
triggers this process is produced initially.
A resolution to this paradox might be provided by
our observation that Cdc2 is not the sole kinase that
phosphorylates Weel in M phase extracts. Based on
the findings in this paper and an earlier study from
our laboratory (Tang et al., 1993), we strongly favor the
idea that multiple kinases, including Cdc2 and an-
other activity (kinase X) phosphorylate Weel at mito-
sis. For example, M phase extracts that have been
depleted of active Cdc2/cyclin B by chromatography
on p13-agarose beads nonetheless retain substantial
kinase activity specific for Xenopus Weel (Figure 9)
and fission yeast Weel (Tang et al., 1993). Moreover,
although Xenopus Weel possesses eleven SP/TP-con-
taining motifs, only one or two of them (PITPQR,
PYTPKS) closely resemble potential Cdc2 phosphory-
lation sites (Nigg, 1991). There are four sequences,
namely PITPQR (see above), PGTPLH, PYTPKS (see
above), and PFTPES, that fit the consensus for recog-
nition by MAP kinases (Thomas, 1992). Finally, the
PITPQR sequence, as well as an additional motif (LL-
TPVF), fit the criteria for phosphorylation by the
MPM-2 epitope (ME) kinase (Westendorf et al., 1994).
The MPM-2 epitope is recognized by a monoclonal
antibody which reacts with a phosphopeptide moiety
present on a large number of mitotic phosphoproteins,
including cell cycle regulatory factors such as the
Cdc25 protein (Kuang et al., 1994). The parallels be-
tween Weel and Cdc25 regulation raised the possibil-
ity that Weel also might be an MPM-2 antigen. In-
deed, we found that the mitotic form of Weel reacts
strongly with MPM-2 antibodies. The identity of the
ME kinase(s) has not been established, but published
studies have suggested that it does not correspond to
Cdc2 (Kuang and Ashorn, 1993; Kuang et al., 1994)
[also see Westendorf et al. (1994)]. Curiously, this sup-
position is not consistent with our finding that Weel
phosphorylated by Cdc2 in vitro becomes an MPM-2
antigen. However, the recognition sites for Cdc2 and
the putative ME kinase share common features (Wes-
tendorf et al., 1994). Therefore, it is likely that there
may be overlap in the phosphorylations carried out by
these two enzymes. It will be highly important to
identify the other kinase that phosphorylates Weel,
since this activity is an excellent candidate for the
factor that tips the balance between Weel and Cdc25
so as to trigger the tyrosine dephosphorylation of
Cdc2 at the threshold of mitosis.
In the fission yeast and frog systems, the Weel
protein kinase has been implicated in various check-
points that control the orderly progression of the cell
cycle. In fission yeast, the Weel protein is clearly
involved in controlling the size at which cells enter
mitosis (Nurse, 1975; Russell and Nurse, 1987). More-
over, although the inactivation of Weel function alone
in fission yeast does not perturb the DNA replication
checkpoint (Enoch and Nurse, 1990), the simultaneous
elimination of the Mikl protein (a kinase that appears
to be redundant with Weel) (Lundgren et al., 1991)
renders cells incapable of arresting the cell cycle in the
presence of replication inhibitors such as hydroxyu-
rea. Similarly, it has been proposed that a Cdc2-spe-
cific tyrosine kinase activity in Xenopus extracts might
be pivotal for the replication checkpoint (Smythe and
Newport, 1992). The activity of the Xenopus Weel-like
kinase described in this paper appears not to be mod-
ulated directly by the presence of unreplicated DNA.
In other studies, we have shown that total Cdc2-spe-
cific tyrosine kinase activity is not increased in aphidi-
colin-containing Xenopus egg extracts (A. Kumagai
and W. G. Dunphy, unpublished data). Thus, it does
not appear that the Weel kinase(s) in Xenopus extracts
are directly modulated by the replication checkpoint.
In vertebrates such as Xenopus, Cdc2 is negatively
regulated by phosphorylation on both Tyr-15 and
Thr-14. The Xenopus Weel homolog, like the previ-
ously identified human Weel homolog (Igarashi
et al., 1991; Parker and Piwnica-Worms, 1992;
McGowan and Russell, 1993), clearly phosphory-
lates Cdc2 only on Tyr-15. This observation is con-
sistent with the fact that Xenopus Weel is a soluble
enzyme, whereas the kinase that phosphorylates
Thr-14 has been reported to be tightly associated
with the cellular membrane fraction (Kornbluth et
al., 1994). In this study, we have not addressed the
intracellular localization of Weel (e.g., cytosolic vs.
nuclear), but interestingly the sequence of Weel
does contain one or more good candidates for a
nuclear localization signal (NLS). One such region
(KRLDGCFYAIKRSKK, residues 229-243) matches
well the bipartite NLS found in nucleoplasmin and
dozens of other nuclear proteins (Dingwall and Las-
key, 1991). This sequence is found near kinase sub-
domains I and II and is well conserved in the human
Weel homolog. However, since there are other basic
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stretches in the Xenopus Weel sequence (KKLK,
KRKER, RGRKR), the definitive identification of an
NLS within Xenopus Weel must rely upon system-
atic mutagenesis studies.
In conclusion, we have provided an overview of
how a Weel-like tyrosine kinase specific for Cdc2 is
regulated during the early embryonic cell cycle in the
Xenopus system. Eventually, the elucidation of how
the various enzymes that act upon Weel (e.g, the
Weel-stimulatory form of PP2A and the multiple
Weel-inhibitory kinases) are controlled will be essen-
tial to obtain a comprehensive view of how cells exe-
cute mitosis faithfully.
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